Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Drug Design and Discovery
Drug Design and Discovery is not currently indexed in Scopus. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1029-2322Verify ISSN ↗1055-9612Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Drug Design and Discovery indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (1991–2003).
What is the impact factor of Drug Design and Discovery?
Drug Design and Discovery has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Drug Design and Discovery and what is its ISSN?
Drug Design and Discovery is published by Taylor and Francis Ltd. Its print ISSN is 1029-2322 and its online ISSN is 1055-9612.
Is Drug Design and Discovery in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Drug Design and Discovery open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Drug Design and Discovery for 13 years, between 1991 and 2003. Coverage ended in 2003, 23 years ago, and Scopus now lists the title as inactive.
How well cited is Drug Design and Discovery? — open metrics via OpenAlex
Drug Design and Discovery has an h-index of 9 and a 2-year mean of 0.2 citations per paper (OpenAlex).
Drug Design and Discovery published 5 papers in 2024; its busiest recent year was 2003 with 26. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Drug Design and Discovery? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2003. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2003
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Taylor and Francis Ltd.
Taylor and Francis Ltd. has 1596 other titles in our data; 1206 are currently indexed in Scopus.
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.